Effects of the ultra-short-acting beta-blocker Esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery
Background/Aim: Esmolol is an ultra-short-acting, easily titratable b-adrenergic receptor antagonist used for urgent treatment of hypertension and tachycardia in non-surgical and surgical settings. Aim of this clinical study was to investigate its cardiovascular effects and quality of the emergence...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN SR |
Publicado: |
Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/81ef032ae0c341a2b4a97b4e71a2b907 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:81ef032ae0c341a2b4a97b4e71a2b907 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:81ef032ae0c341a2b4a97b4e71a2b9072021-12-05T21:31:53ZEffects of the ultra-short-acting beta-blocker Esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery2490-33292303-795410.5937/scriptamed52-34205https://doaj.org/article/81ef032ae0c341a2b4a97b4e71a2b9072021-01-01T00:00:00Zhttps://scindeks-clanci.ceon.rs/data/pdf/2490-3329/2021/2490-33292103187L.pdfhttps://doaj.org/toc/2490-3329https://doaj.org/toc/2303-7954Background/Aim: Esmolol is an ultra-short-acting, easily titratable b-adrenergic receptor antagonist used for urgent treatment of hypertension and tachycardia in non-surgical and surgical settings. Aim of this clinical study was to investigate its cardiovascular effects and quality of the emergence from anaesthesia in patients scheduled for elective plastic surgery under general balanced anaesthesia. Methods: A total of 30 ASA I/II patients were randomised in two groups of similar demographic characteristics and baseline values of cardiovascular parameters. Esmolol group received esmolol dissolved in glucose 5 % as an intravenous infusion, 0.3 mg/kg/min during the first 5 min and at a rate of 0.1 mg/kg/ min thereafter. Control patients received the solvent only, at the same rate and volume. General balanced anaesthesia was induced with thiopentone sodium and fentanyl and maintained with nitrous oxide and oxygen. Neuromuscular relaxation was assured with pancuronium bromide and was antagonised at the end of operation with atropine and neostigmine. Systolic and diastolic blood pressure and heart rate were registered at all critical phases: (1) immediately prior to the induction (baseline value), (2) induction to anaesthesia, (3) tracheal intubation, (4) first skin incision, (5) surgical manipulation with organs, (6) suture of the surgical wound and (7) tracheal extubation. Drug consumption and quality of postoperative recovery were monitored. Results: In most of the critical phases of anaesthesia and operation, patients from the Esmolol group had significantly lower values of cardiovascular parameters than the patients from the Control group. Esmolol-treated patients needed less fentanyl, droperidol and pancuronium and had faster and smoother emergence from anaesthesia than the control patients. Conclusion: Esmolol improved haemodynamics and post-anaesthesia recovery in patients undergoing elective plastic surgery under general balanced anaesthesia.Lončar-Stojiljković DraganaMedical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicinearticleesmololbeta-blockersanaesthesiaplastic surgerycardiovascular parametersMedicineRENSRScripta Medica, Vol 52, Iss 3, Pp 187-192 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN SR |
topic |
esmolol beta-blockers anaesthesia plastic surgery cardiovascular parameters Medicine R |
spellingShingle |
esmolol beta-blockers anaesthesia plastic surgery cardiovascular parameters Medicine R Lončar-Stojiljković Dragana Effects of the ultra-short-acting beta-blocker Esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery |
description |
Background/Aim: Esmolol is an ultra-short-acting, easily titratable b-adrenergic receptor antagonist used for urgent treatment of hypertension and tachycardia in non-surgical and surgical settings. Aim of this clinical study was to investigate its cardiovascular effects and quality of the emergence from anaesthesia in patients scheduled for elective plastic surgery under general balanced anaesthesia. Methods: A total of 30 ASA I/II patients were randomised in two groups of similar demographic characteristics and baseline values of cardiovascular parameters. Esmolol group received esmolol dissolved in glucose 5 % as an intravenous infusion, 0.3 mg/kg/min during the first 5 min and at a rate of 0.1 mg/kg/ min thereafter. Control patients received the solvent only, at the same rate and volume. General balanced anaesthesia was induced with thiopentone sodium and fentanyl and maintained with nitrous oxide and oxygen. Neuromuscular relaxation was assured with pancuronium bromide and was antagonised at the end of operation with atropine and neostigmine. Systolic and diastolic blood pressure and heart rate were registered at all critical phases: (1) immediately prior to the induction (baseline value), (2) induction to anaesthesia, (3) tracheal intubation, (4) first skin incision, (5) surgical manipulation with organs, (6) suture of the surgical wound and (7) tracheal extubation. Drug consumption and quality of postoperative recovery were monitored. Results: In most of the critical phases of anaesthesia and operation, patients from the Esmolol group had significantly lower values of cardiovascular parameters than the patients from the Control group. Esmolol-treated patients needed less fentanyl, droperidol and pancuronium and had faster and smoother emergence from anaesthesia than the control patients. Conclusion: Esmolol improved haemodynamics and post-anaesthesia recovery in patients undergoing elective plastic surgery under general balanced anaesthesia. |
format |
article |
author |
Lončar-Stojiljković Dragana |
author_facet |
Lončar-Stojiljković Dragana |
author_sort |
Lončar-Stojiljković Dragana |
title |
Effects of the ultra-short-acting beta-blocker Esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery |
title_short |
Effects of the ultra-short-acting beta-blocker Esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery |
title_full |
Effects of the ultra-short-acting beta-blocker Esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery |
title_fullStr |
Effects of the ultra-short-acting beta-blocker Esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery |
title_full_unstemmed |
Effects of the ultra-short-acting beta-blocker Esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery |
title_sort |
effects of the ultra-short-acting beta-blocker esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery |
publisher |
Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine |
publishDate |
2021 |
url |
https://doaj.org/article/81ef032ae0c341a2b4a97b4e71a2b907 |
work_keys_str_mv |
AT loncarstojiljkovicdragana effectsoftheultrashortactingbetablockeresmololinfusiononcardiovascularparametersandqualityofpostoperativerecoveryinpatientsscheduledforelectiveplasticsurgery |
_version_ |
1718370953503703040 |